Last reviewed · How we verify

NCT05963451

Brain, Psychological and Epigenetic Determinants for Optimizing the Treatment of Chronic Low Back Pain

Recruiting now Last updated 13 September 2023
What this trial tests

trial testing No intervention in Chronic Low-back Pain in 80 participants. Currently enrolling.

Timeline
7 September 2023
Primary endpoint
16 July 2027
16 July 2027

Quick facts

Lead sponsorUniversité de Sherbrooke
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment80
Start date7 September 2023
Primary completion16 July 2027
Estimated completion16 July 2027
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Université de Sherbrooke — full company profile →

Who can join

Adults 18 to 75, any sex, with Chronic Low-back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to better understand the role of the brain in chronic low back pain patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Chronic Low-back Pain

Currently open trials in the same condition.

Other Université de Sherbrooke trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05963451.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing